165 related articles for article (PubMed ID: 25343528)
21. Cytokine production and helper T cell subsets in Vogt-Koyanagi-Harada's disease.
Imai Y; Sugita M; Nakamura S; Toriyama S; Ohno S
Curr Eye Res; 2001 Apr; 22(4):312-8. PubMed ID: 11462171
[TBL] [Abstract][Full Text] [Related]
22. Upregulation of T-bet expression in peripheral blood mononuclear cells during Vogt-Koyanagi-Harada disease.
Li B; Yang P; Zhou H; Huang X; Jin H; Chu L; Gao Y; Zhu L; Kijlstra A
Br J Ophthalmol; 2005 Nov; 89(11):1410-2. PubMed ID: 16234441
[TBL] [Abstract][Full Text] [Related]
23. Dominance of activated T cells and interleukin-6 in aqueous humor in Vogt-Koyanagi-Harada disease.
Norose K; Yano A; Wang XC; Tokushima T; Umihira J; Seki A; Nohara M; Segawa K
Invest Ophthalmol Vis Sci; 1994 Jan; 35(1):33-9. PubMed ID: 8300361
[TBL] [Abstract][Full Text] [Related]
24. TLR3 and TLR4 But not TLR2 are Involved in Vogt-Koyanagi- Harada Disease by Triggering Proinflammatory Cytokines Production Through Promoting the Production of Mitochondrial Reactive Oxygen Species.
Liang L; Tan X; Zhou Q; Tian Y; Kijlstra A; Yang P
Curr Mol Med; 2015; 15(6):529-42. PubMed ID: 26238371
[TBL] [Abstract][Full Text] [Related]
25. Elevated serum IL-23 correlates with intraocular inflammation after cataract surgery in patients with Vogt-Koyanagi-Harada disease.
Jiang S; Liu X; Luo L; Qu B; Huang X; Xu L; Lin Y; Ye S; Liu Y
Br J Ophthalmol; 2010 Aug; 94(8):1078-82. PubMed ID: 19910285
[TBL] [Abstract][Full Text] [Related]
26. Higher Expression of NOD1 and NOD2 is Associated with Vogt-Koyanagi-Harada (VKH) Syndrome But Not Behcet's Disease (BD).
Deng B; Ye Z; Li L; Zhang D; Zhu Y; He Y; Wang C; Wu L; Kijlstra A; Yang P
Curr Mol Med; 2016; 16(4):424-35. PubMed ID: 26980698
[TBL] [Abstract][Full Text] [Related]
27. Disabled-2 (DAB2) Overexpression Inhibits Monocyte-Derived Dendritic Cells' Function in Vogt-Koyanagi-Harada Disease.
Yi S; Chang R; Hu J; Qiu Y; Wang Q; Cao Q; Yuan G; Su G; Zhou C; Wang Y; Kijlstra A; Yang P
Invest Ophthalmol Vis Sci; 2018 Sep; 59(11):4662-4669. PubMed ID: 30267088
[TBL] [Abstract][Full Text] [Related]
28. Decreased Expression of TGR5 in Vogt-Koyanagi-Harada (VKH) Disease.
Yang J; Hu J; Feng L; Yi S; Ye Z; Lin M; Liu X; Pu Y; Kijlstra A; Yang P; Li H
Ocul Immunol Inflamm; 2020; 28(2):200-208. PubMed ID: 30794473
[No Abstract] [Full Text] [Related]
29. Decreased 1,25-Dihydroxyvitamin D3 level is involved in the pathogenesis of Vogt-Koyanagi-Harada (VKH) disease.
Yi X; Yang P; Sun M; Yang Y; Li F
Mol Vis; 2011 Mar; 17():673-9. PubMed ID: 21403851
[TBL] [Abstract][Full Text] [Related]
30. Ocular infiltrating CD4+ T cells from patients with Vogt-Koyanagi-Harada disease recognize human melanocyte antigens.
Sugita S; Takase H; Taguchi C; Imai Y; Kamoi K; Kawaguchi T; Sugamoto Y; Futagami Y; Itoh K; Mochizuki M
Invest Ophthalmol Vis Sci; 2006 Jun; 47(6):2547-54. PubMed ID: 16723469
[TBL] [Abstract][Full Text] [Related]
31. T-cell recognition and cytokine profile induced by melanocyte epitopes in patients with HLA-DRB1*0405-positive and -negative Vogt-Koyanagi-Harada uveitis.
Damico FM; Cunha-Neto E; Goldberg AC; Iwai LK; Marin ML; Hammer J; Kalil J; Yamamoto JH
Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2465-71. PubMed ID: 15980237
[TBL] [Abstract][Full Text] [Related]
32. Cyclosporin A regulates interleukin-1beta and interleukin-6 expression in gingiva: implications for gingival overgrowth.
Myrillas TT; Linden GJ; Marley JJ; Irwin CR
J Periodontol; 1999 Mar; 70(3):294-300. PubMed ID: 10225546
[TBL] [Abstract][Full Text] [Related]
33. Decreased microRNA-155 expression in ocular Behcet's disease but not in Vogt Koyanagi Harada syndrome.
Zhou Q; Xiao X; Wang C; Zhang X; Li F; Zhou Y; Kijlstra A; Yang P
Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5665-74. PubMed ID: 22815348
[TBL] [Abstract][Full Text] [Related]
34. Cytokine profiles in aqueous humor of patients with different clinical entities of endogenous uveitis.
El-Asrar AM; Struyf S; Kangave D; Al-Obeidan SS; Opdenakker G; Geboes K; Van Damme J
Clin Immunol; 2011 May; 139(2):177-84. PubMed ID: 21334264
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-20a-5p suppresses IL-17 production by targeting OSM and CCL1 in patients with Vogt-Koyanagi-Harada disease.
Chang R; Yi S; Tan X; Huang Y; Wang Q; Su G; Zhou C; Cao Q; Yuan G; Kijlstra A; Yang P
Br J Ophthalmol; 2018 Feb; 102(2):282-290. PubMed ID: 28972028
[TBL] [Abstract][Full Text] [Related]
36. Melanoma specific Th1 cytotoxic T lymphocyte lines in Vogt-Koyanagi-Harada disease.
Norose K; Yano A
Br J Ophthalmol; 1996 Nov; 80(11):1002-8. PubMed ID: 8976730
[TBL] [Abstract][Full Text] [Related]
37. Promoter Hypermethylation of GATA3, IL-4, and TGF-β Confers Susceptibility to Vogt-Koyanagi-Harada Disease in Han Chinese.
Zhu Y; Yu H; Qiu Y; Ye Z; Su W; Deng J; Cao Q; Yuan G; Kijlstra A; Yang P
Invest Ophthalmol Vis Sci; 2017 Mar; 58(3):1529-1536. PubMed ID: 28278322
[TBL] [Abstract][Full Text] [Related]
38. Increased Complement 3a Receptor is Associated with Behcet's disease and Vogt-Koyanagi-Harada disease.
Wang C; Cao S; Zhang D; Li H; Kijlstra A; Yang P
Sci Rep; 2017 Nov; 7(1):15579. PubMed ID: 29138505
[TBL] [Abstract][Full Text] [Related]
39. Glucocorticoid Receptor-α and MKP-1 as Candidate Biomarkers for Treatment Response and Disease Activity in Vogt-Koyanagi-Harada Disease.
Urzua CA; Chen P; Chaigne-Delalande B; Liu B; Anguita R; Guerrero J; Sabat P; Velasquez V; Sen HN; Lee RWJ; Goecke A
Am J Ophthalmol; 2019 Nov; 207():319-325. PubMed ID: 31323199
[TBL] [Abstract][Full Text] [Related]
40. Band-shaped keratopathy in Chinese patients with Vogt-Koyanagi-Harada syndrome.
Yang P; Sun M
Cornea; 2011 Dec; 30(12):1336-40. PubMed ID: 21934492
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
